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Introduction: Patients’ views on testing for cancer may influence their help-seeking behaviour; thereby contributing to diagnostic delays and worse cancer outcomes. A recent study showed that patients (mainly of white ethnic origin) were willing to be investigated for lung, pancreas and colorectal cancers at risk levels lower than offered within the National Health Services (NHS). This may be different in the ethnic minority population. Minorities have lower awareness of cancer symptoms and are less likely to seek help promptly when symptomatic. 
Aim: To investigate whether black men (of African or Caribbean origin) would choose to be tested for prostate cancer compared to the white majority. Blacks are more susceptible to this cancer. 
Method: In an electronic vignette-based study, we aim to recruit ~572 men aged ≥40 years attending 4 general practices in Bristol. The vignettes describe possible prostate cancer symptoms with risk levels of 2%, 5%, and 10%, selected at random. Analysis will include simple descriptive statistics and regression techniques with preference to test as the primary outcome and ethnicity as the main exposure variable.  
Result: So far, 496 men have completed the vignette for at least one risk level. 399 (80%) opted to be investigated at the first risk level offered, with 204 (93%) acceptance by whites, and 163 (72%) by blacks. In multivariable analysis, preference for investigation was strongly associated with increasing risk (odds ratio 4.3 95%CI: 2.3-7.9 for an increase from 2% risk to 5% risk) and with ethnicity (Black compared to White men, odds ratio 0.15 95%CI: 0.078-0.28; both p<0.001). 
Conclusion: Initial findings shows that Black men are less willing to opt for investigation at any risk level of prostate cancer compared to their white counterparts. These are, however, preliminary findings, and so the full results will be reported at the conference.


